T-switch-ing TCR specificity

Andrew Y Hu1, Cristina Puig-Saus2

  • 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, CA, USA; Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, CA, USA.

Immunity
|December 11, 2024
PubMed

Central tolerance restricts T cells that target self-antigens. In this issue of Immunity, Abdelfattah et al.1 describe a method to generate self-reactive T cell receptors (TCRs) by directed evolution of non-autoreactive TCRs to recognize self-antigen peptides and demonstrate potential for T cells engineered with such receptors in immunotherapy.